These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34004261)

  • 1. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis.
    Wang W; Xu C; Li X; Wang Z; Yang J; Shen Y; Shi M; Chen L; Zhang L; Guo Y; Wang B; Zhang T; Pu Y
    J Ethnopharmacol; 2021 Sep; 277():114197. PubMed ID: 34004261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis.
    Luo Y; Fu S; Liu Y; Kong S; Liao Q; Lin L; Li H
    J Ethnopharmacol; 2024 May; 326():117990. PubMed ID: 38423412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
    Chen G; Yang Y; Liu M; Teng Z; Ye J; Xu Y; Cai X; Cheng X; Yang J; Hu C; Wang M; Cao P
    J Ethnopharmacol; 2015 May; 166():149-56. PubMed ID: 25794808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Banxia Xiexin decoction ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase (Akt)/mitogen-activated protein kinase (MAPK) signaling pathway.
    Ji W; Liu W; Huo Y; Hu C; Zhang Y
    Biotechnol Appl Biochem; 2023 Aug; 70(4):1530-1542. PubMed ID: 36806191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive components of Banxia Xiexin Decoction for the treatment of gastrointestinal diseases based on flavor-oriented analysis.
    Wang W; Gu W; He C; Zhang T; Shen Y; Pu Y
    J Ethnopharmacol; 2022 Jun; 291():115085. PubMed ID: 35150814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Banxia Xiexin Decoction on intestinal flora of mice with ulcerative colitis induced by dextran sodium sulfate].
    Chen J; Zhang LK; Gu WC; Zhang XS; Li L; Han T; Liu XJ; Huang HL
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2871-2880. PubMed ID: 34296588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.
    Yu Y; Zhang G; Han T; Huang H
    BMC Complement Med Ther; 2020 Jun; 20(1):199. PubMed ID: 32600331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
    Ji W; Wang T; Xu Y; An R; Liang K; Wang X
    Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banxia Xiexin decoction combined with 5-ASA protects against CPT-11-induced intestinal dysfunction in rats via inhibiting TLR4/NF-κB signaling pathway.
    Zou Y; Wang Y; Zhou W; Pei J
    Immun Inflamm Dis; 2024 Jun; 12(6):e1208. PubMed ID: 38860759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of Patrinia villosa on TNBS-induced ulcerative colitis via metabolism, vitamin D receptor and NF-κB signaling pathways.
    Wang J; Wang X; Ma X; Xu B; Chen L; Chen C; Liu W; Liu Y; Xiang Z
    J Ethnopharmacol; 2022 Apr; 288():114989. PubMed ID: 35032589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the bioactive components of Banxia Xiexin Decoction that protect against CPT-11-induced intestinal toxicity via UPLC-based spectrum-effect relationship analyses.
    Shi JW; Li ZZ; Wu JS; Jin WY; Chang XY; Sun H; Dong L; Jiang ZP; Shi Y
    J Ethnopharmacol; 2021 Feb; 266():113421. PubMed ID: 33022337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammation effect of Qingchang suppository in ulcerative colitis through JAK2/STAT3 signaling pathway in vitro and in vivo.
    Yu T; Li Z; Xu L; Yang M; Zhou X
    J Ethnopharmacol; 2021 Feb; 266():113442. PubMed ID: 33027643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active components alignment of Gegenqinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stress.
    Xu BL; Zhang GJ; Ji YB
    J Ethnopharmacol; 2015 Mar; 162():253-60. PubMed ID: 25557032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].
    Luo YT; Lin LF; Liu YL; Shi GL; Wu YQ; Yang AH; Li H
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5753-5761. PubMed ID: 33496116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema.
    Cui Y; Hu J; Li Y; Au R; Fang Y; Cheng C; Xu F; Li W; Wu Y; Zhu L; Shen H
    Drug Des Devel Ther; 2023; 17():3453-3472. PubMed ID: 38024534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA.
    Jiang Y; Huang Y; Hu Y; Yang Y; You F; Hu Q; Li X; Zhao Z
    J Ethnopharmacol; 2024 Jun; 328():117932. PubMed ID: 38382652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
    Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
    Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Banxia Xiexin Decoction inhibiting colitis-associated colorectal cancer infected with Fusobacterium nucleatum by regulating Wnt/β-catenin pathway].
    Jiang YF; Huang YQ; Hu YE; Yang Y; Zheng C; You FM; Zhao ZY
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1266-1274. PubMed ID: 38621974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.
    Li B; Rui J; Ding X; Yang X
    J Ethnopharmacol; 2019 Apr; 233():158-168. PubMed ID: 30590198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Banxia Xiexin Decoction () Treats Diabetic Gastroparesis through PLC-IP
    Wang B; Zeng KW; Hong ZF; Ti GX; Wang LY; Lu P; Liu Z
    Chin J Integr Med; 2020 Nov; 26(11):833-838. PubMed ID: 32418177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.